TY  - JOUR 
AU  - Gutierrez-Enriquez, S
AU  - Bonache, S
AU  - de Garibay, GR
AU  - Osorio, A
AU  - Santamariña Pena, Marta
AU  - Cajal, TRY
AU  - Esteban-Cardenosa, E
AU  - Tenes, A
AU  - Yanowsky, K
AU  - Barroso, A
AU  - Montalban, G
AU  - Blanco Pérez, Ana
AU  - Cornet, M
AU  - Gadea, N
AU  - Infante, M
AU  - Caldes, T
AU  - Diaz-Rubio, E
AU  - Balmana, J
AU  - Lasa, A
AU  - Vega Gliemmo, Ana
AU  - Benitez, J
AU  - de la Hoya, M
AU  - Diez, O
PY  - 2014
SN  - 0020-7136
UR  - http://hdl.handle.net/20.500.11940/7974
AB  - RAD51D mutations have been recently identified in breast (BC) and ovarian cancer (OC) families. Although an etiological role in OC appears to be present, the association of RAD51D mutations and BC risk is more unclear. We aimed to determine the...
LA  - eng
KW  - Adult
KW  - Aged
KW  - Breast Neoplasms
KW  - Female
KW  - Humans
KW  - Hysterectomy
KW  - Middle Aged
KW  - Ovarian Neoplasms
KW  - Ovariectomy
KW  - Proportional Hazards Models
KW  - Risk Factors
KW  - Salpingectomy
KW  - Uterine Neoplasms
KW  - Young Adult
TI  - About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants
DO  - 10.1002/ijc.28540
T2  - INTERNATIONAL JOURNAL OF CANCER
M2  - 2088
VL  - 134
ER  -